Analyses of the Inducible Cyclic Adenosine 3′,5′-Monophosphate Early Repressor (ICER) and cAMP Response Element Binding Protein (CREB) in HL60 Cells: New Insight Leukemogenesis?.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 2251-2251
Author(s):  
Martina Pigazzi ◽  
Elena Manara ◽  
Marta Campo DellOrto ◽  
Emanuela Ricotti ◽  
Giuseppe Basso

Abstract The cyclic AMP response-element binding protein (CREB) is a transcription factor that controls genes that regulate cell differentiation, proliferation and survival. CREB protein overexpression has previously been demonstrated in lymphoid and myeloid leukemia. In contrast, it is lower in healthy samples. To understand CREB role in hematopoiesis and leukemogenesis we focused on ICER (Inducible Cyclic Adenosine 3′,5′-monophosphate early repressor). We hypothesize that ICER, CREB endogenous antagonist, deserves a special consideration in CREB function and in the activation of gene expression. ICER directs its specific binding to cAMP response elements (CREs) functioning as a potent repressor of CREB binding and therefore of cAMP-induced transcription. It has been already demonstrated that ICER directly participates in cell fate in other systems. We have previously found that ICER mRNA was at low level at diagnosis of leukemia, whereas it increased in documented remission samples collected during follow up. We constructed an expression vector for ICER and induced its exogenous expression in HL60 cells. We then tested transcription and translation of a series of genes known to have a direct link with the members of the cAMP/CREB pathway by quantitative gene expression analysis and western blot. To determine wheter ICER protein affected identical cellular targets of CREB by repressing CRE containing promoters, we examined luciferase activity when directed by a promoter made up of 4XCREs sequences post ICER transient induction. By chromatin immunoprecipitation assay (ChIP) we looked at specific genes promoters binding, also in permanent ectopic ICER expression system. Results revealed that ICER protein was detected after 24 hours post transfection with sustained induction after 48 hours, whereas CREB mRNA and protein are down regulated. Density Array made up of 96 genes cited in CREB database (http://natural.salk.edu/CREB) for the high predictive value to contain CRE consensus sequence in their promoter revealed a wide genes expression alterations occurring over time post ICER exogenous expression, counteracting CREB transcriptional function. For some genes we confirmed that mRNA down regulation was representative of protein downregulation. We revealed that luciferase activity was strongly reduced by ICER transient induction. Moreover ChIP analyses revealed that CREB binds to the Bcl-2, ICER and CyA1 promoters in HL60 controlling their transcription. This binding was strongly reduced, in particular for Bcl-2, after ICER stable transfection in HL60 confirming its important role in gene expression reduction. Finally, we hypothesize that CREB over expression might up-regulate target genes, affecting cell proliferation and survival at diagnosis of leukaemia. Insufficient ICER expression might fail to counteract these events. These findings represent an important first step in the understanding of the physiological processes linked to the cAMP/CREB/ICER pathway. The future understanding of ICER role in blocking cAMP activation pathway and the finding of a pool of CREB target genes in HL60 may help understanding leukemogenesis.

Endocrinology ◽  
2009 ◽  
Vol 150 (7) ◽  
pp. 3417-3424 ◽  
Author(s):  
Koshi Hashimoto ◽  
Emi Ishida ◽  
Shunichi Matsumoto ◽  
Shuichi Okada ◽  
Masanobu Yamada ◽  
...  

The molecular mechanism of thyroid hormone (TH) effects to fatty acid metabolism in liver is yet to be clear. The carbohydrate response element-binding protein (ChREBP) as well as sterol response element-binding protein (SREBP)-1c plays a pivotal role in hepatic lipogenesis. Both SREBP-1c and ChREBP are target genes of liver X receptors (LXRs). Because LXRs and TH receptors (TRs) cross talk mutually in many aspects of transcription, we examined whether TRs regulate the mouse ChREBP gene expression. In the current study, we demonstrated that TH up-regulated mouse ChREBP mRNA and protein expression in liver. Run-on and luciferase assays showed that TH and TR-β1 positively regulated the ChREBP gene transcription. The mouse ChREBP gene promoter contains two direct repeat-4 sites (LXRE1 and LXRE2) and EMSAs demonstrated that LXR-α and TR-β1 prefer to bind LXRE1 and LXRE2, respectively. The direct repeat-4 deletion and LXRE2 mutants of the promoter deteriorate the positive regulation by TR-β1, indicating that LXRE2 is functionally important for the regulation. We also showed that human ChREBP gene expression and promoter activities were up-regulated by TH. These data suggest that ChREBP mRNA expression is positively regulated by TR-β1 and TH at the transcriptional level in mammals. This novel observation indicates that TH fine-tunes hepatic lipogenesis via regulating SREBP-1c and ChREBP gene expression reciprocally.


2005 ◽  
Vol 280 (49) ◽  
pp. 40398-40401 ◽  
Author(s):  
Junghee Lee ◽  
Chun-Hyung Kim ◽  
David K. Simon ◽  
Lyaylya R. Aminova ◽  
Alexander Y. Andreyev ◽  
...  

SLEEP ◽  
2020 ◽  
Author(s):  
Mathieu E Wimmer ◽  
Rosa Cui ◽  
Jennifer M Blackwell ◽  
Ted Abel

Abstract The molecular and intracellular signaling processes that control sleep and wake states remain largely unknown. A consistent observation is that the cyclic adenosine monophosphate (AMP) response element-binding protein (CREB), an activity-dependent transcription factor, is differentially activated during sleep and wakefulness. CREB is phosphorylated by the cyclic AMP/protein kinase A (cAMP/PKA) signaling pathway as well as other kinases, and phosphorylated CREB promotes the transcription of target genes. Genetic studies in flies and mice suggest that CREB signaling influences sleep/wake states by promoting and stabilizing wakefulness. However, it remains unclear where in the brain CREB is required to drive wakefulness. In rats, CREB phosphorylation increases in the cerebral cortex during wakefulness and decreases during sleep, but it is not known if this change is functionally relevant to the maintenance of wakefulness. Here, we used the Cre/lox system to conditionally delete CREB in the forebrain (FB) and in the locus coeruleus (LC), two regions known to be important for the production of arousal and wakefulness. We used polysomnography to measure sleep/wake levels and sleep architecture in conditional CREB mutant mice and control littermates. We found that FB-specific deletion of CREB decreased wakefulness and increased non-rapid eye movement sleep. Mice lacking CREB in the FB were unable to sustain normal periods of wakefulness. On the other hand, deletion of CREB from LC neurons did not change sleep/wake levels or sleep/wake architecture. Taken together, these results suggest that CREB is required in neurons within the FB but not in the LC to promote and stabilize wakefulness.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 4727-4727
Author(s):  
Claudia Tregnago ◽  
Sanja Aveic ◽  
Elena Manara ◽  
Martina Pigazzi ◽  
Giuseppe Basso

Abstract Abstract 4727 Introduction. Transcription factors has been widely confirmed to play a central role in acute leukemia, and among them the cyclic-adenosine monophosphate response element-binding protein (CREB) was identified to be involved in triggering acute myeloid leukemia. CREB protein overexpression has been found in the bone marrow of most pediatric patients with acute leukemia, and it has been shown to induce myeloid leukemia progression in vitro and in vivo by driving the upregulation of a series of target genes. CREB is evolutionarily conserved from invertebrates to human, and although the main focus of zebrafish research has traditionally been developmental biology, this model is currently used for cancer research. In fact, tumors induced in ZF have similar morphology and activated signaling pathways of human cancers. Aim. We aimed to develop a ZF harboring CREB overexpression in myeloid precursors, and by monitoring the induced myeloid malignancy, we will characterize CREB signaling and its involvement in the myeloid transformation process. Results. Using a Multisite Gateway System we constructed a vector containing human-CREB gene fused to EGFP, driven by an early myeloid promoter, zPu.1, to induce CREB overexpression specifically in the myeloid lineage of ZF. We injected the EGFP-CREB plasmid into one-cell stage zebrafish embryos, and monitored its expression during early development. Results showed that CREB was expressed in ZF zones typical of myelopoiesis, such as in the intermediate cell mass and anterior lateral mesoderm migrating through the yolk from 12 to 48 hours post-fertilization (hpf), and few cells circulating throughout the embryo from 24 hpf. CREB transcriptional activity on cAMP response elements (CREs) was measured and confirmed by luciferase assay. The co-localization of EGFP-CREB with the CRE-mCherry reporter was seen by fluorescence microscopy analysis. To test CREB target gene expression, embryos injected with CREB or Empty vector were subjected to RNA extraction and RQ-PCR. CREB over-expression was documented (up to 103 fold), and c-myb, stat3, rb, runx1, cyclins A, B, D1 and E2 were found upregulate at 24 and 48 hpf. By RNA whole mount in situ hybridization, we revealed pu.1, mpo, gata1 and fli.1 increased signals, suggesting a general disruption of the main hematopoietic factors. Ten CREB-injected zebrafish have been grown to adulthood and all of them displayed an abnormal/sick phenotype with abdominal enlargement and swelling from 10 to 12 months. Histochemical H&E staining performed on paraffin sections revealed an abdominal tumor and metastatic infiltration in kidney, skin, gills, muscles, adipose tissue. PAS staining identified the myeloid character of the tumor mass and kidney marrow. Wright-Giemsa and ANAE staining showed the predominance of clonal monocytes on appositions of tumor mass and kidney marrow of sick ZF. Tumor mass cell sorting displayed a clonal feature of the tumor with an enrichment of the myeloid-monocitic compartment. RNA extraction from the mass shows CREB overexpression as well as its target genes (c-myb, runx1, cyclin A1, cyclin B1, cyclin B2, cyclin E1), confirming CREB involvement in this tumor formation. Conclusion. We demonstrated that CREB overexpression recapitulates myeloproliferative disorder in ZF, supporting the ZF as a suitable model for studying CREB-induced leukemia. The discovery through which targets CREB would preferentially mediate the myeloid transformation will help to unravel leukemogenesis. ZF model might be useful to test CREB directed drugs. Disclosures: No relevant conflicts of interest to declare.


2005 ◽  
Vol 46 (5) ◽  
pp. 862-871 ◽  
Author(s):  
Layton Harris Smith ◽  
Matthew S. Petrie ◽  
Jason D. Morrow ◽  
John A. Oates ◽  
Douglas E. Vaughan

Sign in / Sign up

Export Citation Format

Share Document